DVAX is a strong buy for the short term and for the long term. Heplisav will get FDA approval eventually, I believe it.
DVAX will go to $3 in the short period of time. In the midterm, it will be a $5+ stock.
Sentiment: Strong Buy
I believed in Santa Claus....You believe it will get approval?